Balram Bhargava

Indian science administrator

Balram Bhargava ▸ Facts ▸ Comments ▸ News ▸ Videos

Balram Bhargava is an Indian science administrator. He has been appointed for a three-year tenure as the Director-General at the Indian Council of Medical Research, New Delhi and Secretary, Department of Health Research a division under Ministry of Health and Family Welfare, Government of India.

0 shares	Share Tweet Save Post Send



‘No difference in Covid death percentage between first & second wave’: ICMR D-G Dr Balram Bhargava, Director-General (DG) of the Indian Council of Medical Research (ICMR) said there is no change in death rate between the first and second Covid-19 wave. "There is no change in the.. Credit: HT Digital Content Duration: 01:57Published 3 weeks ago

No difference in death percentage between 1st and 2nd COVID wave: ICMR DG Indian Council of Medical Research (ICMR) Chief, Dr. Balram Bhargava on April 19 said that in the second wave of COVID, there is no difference found in the percentage of death in comparison to 1st wave.. Credit: ANI Duration: 01:03Published 3 weeks ago

Covid: Centre explains 5 steps discussed with States to curb virus spread Centre on Saturday spoke on the five steps discussed with the States that have high number of Covid-19 cases. Health Secretary Rajesh Bhushan said that Centre discussed the steps with States to curb.. Credit: HT Digital Content Duration: 09:52Published on March 30, 2021

You Might Like

Only 2-4 infections per 10k found in those vaccinated with two doses: ICMR In a strong validation of the utility of vaccines in combating Covid 19, the Indian Council of Medical Research (ICMR) on Wednesday said only 2-4 per 10,000 “breakthrough” infections were noted in.. IndiaTimes - Published 3 weeks ago
Covid-19 vaccines are disease-modifying, reduce chances of severe infection, mortality: ICMR chief Covid-19 vaccines reduce the chances of developing severe infection and mortality, ICMR chief Balram Bhargava said on Tuesday. IndiaTimes - Published on April 13, 2021
Covishield, Covaxin effective against UK, Brazillian variants; work against South African strain on: Govt Both Covishield and Covaxin vaccines are effective against the UK and the Brazillian variants of coronavirus, while the work against the South African strain was on at several laboratories, the Centre.. IndiaTimes - Published on March 30, 2021

South Africa, Brazil mutated Covid strains have reached India The South African and Brazilian mutant strains of coronavirus have entered the country, apart from the UK variant reported in 187 people so far. Four persons were detected with the South Africa variant.. IndiaTimes - Published on February 16, 2021
Those on blood thinners can receive vaccine, says ICMR Fact-sheets of both Covaxin and Covishield will be revised soon so that people on blood thinners like aspirin and clopidogrel can receive the vaccines, while those on anticoagulants may also take the.. IndiaTimes - Published on January 28, 2021
No irregularity in approval to Covaxin: ICMR In an urgent situation like the Covid pandemic, the drug regulator has the authority to give approval for restricted use to a vaccine based on its safety and immunogenicity data from phase 1 and 2.. IndiaTimes - Published on January 6, 2021

Emergency use of vaccine is based on safety, immunogenicity data, says ICMR chief The Indian Council of Medical Research (ICMR) director Dr Balram Bhargava on Tuesday said that in a pandemic situation, restricted emergency use of the vaccine is considered based on phase 2 safety and.. IndiaTimes - Published on January 5, 2021
ICMR chief Balram Bhargava admitted to AIIMS after testing positive for COVID-19 This comes as India's COVID-19 caseload rose to 99.79 lakh with 22,890 new infections being reported in a day. DNA - Published on December 18, 2020
ICMR chief Balram Bhargava undergoing treatment for Covid-19 at AIIMS Trauma Centre Indian Council of Medical Research (ICMR) Director General Balram Bhargava is undergoing treatment for Covid-19 at the AIIMS Trauma Centre here, official sources said on Friday. Bhargava, who is also a.. IndiaTimes - Published on December 18, 2020
‘Adverse event’ won’t affect vaccine rollout plan: Government ICMR director general Dr Balram Bhargava said adverse events occur with drugs, vaccines or any other health interventions. It is the role of the regulator after collating all the data to ascertain or.. IndiaTimes - Published on December 1, 2020

‘No vaccine for respiratory diseases has 100% efficacy’ No vaccine for respiratory diseases has a 100% efficacy and ones with a 50-100% efficacy may be approved for use against the Covid-19 pandemic, Indian Council for Medical Research (ICMR) director.. IndiaTimes - Published on September 22, 2020
Govt asks states to upload rapid antigen testing data on ICMR portal In a letter to all states and union territories Indian Council for Medical Research director general Balram Bhargava has said that with the use of rapid antigen tests, more and more tests are being.. IndiaTimes - Published on July 16, 2020
Two indigenous Indian vaccines cleared to start human trials, each has 1,000 volunteers India is perceived and is an important player in the global vaccine supply, fast-tracking COVID-19 vaccine development is a moral duty, ICMR chief Balram Bhargava said. DNA - Published on July 14, 2020	No vaccine before 2021, science minister says in release, deletes it A fresh controversy erupted over India’s Covid-19 vaccine timelines with a department of science and technology (DST) press release first mentioning and then deleting a reference to the antidote.. IndiaTimes - Published on July 5, 2020
India is not in community transmission: ICMR There is no community transmission of Covid-19 in the country according to the Indian Council of Medical Research (ICMR) on Thursday. Professor (Dr) Balram Bhargava, DG, ICMR, at a press conference in.. IndiaTimes - Published on June 11, 2020	'No harm, potential benefits': ICMR continues recommendation on use of hydroxychloroquine for preventive treatment Responding to a query on the efficacy of hydroxychloroquine during a media briefing on COVID-19, ICMR chief Balram Bhargava said biological plausibility of HCQ was supporting that it might be an.. DNA - Published on May 26, 2020
Centre asks states to set up exclusive facilities for treating covid-19 patients Addressing reporters on the preparedness of the government for prevention and containment of the disease, health ministry officials said the country has the capacity for conducting around 60,000-70,000.. IndiaTimes - Published on March 22, 2020	72 functional labs for coronavirus testing, private players to be engaged soon: ICMR Private NABL-accredited labs will soon be operationalised across the country, ICMR chief Balram Bhargava said. DNA - Published on March 17, 2020

Balram Bhargava

Indian science administrator

Balram Bhargava ▸ Facts ▸ Comments ▸ News ▸ Videos

You Might Like

Only 2-4 infections per 10k found in those vaccinated with two doses: ICMR

Covid-19 vaccines are disease-modifying, reduce chances of severe infection, mortality: ICMR chief

Covishield, Covaxin effective against UK, Brazillian variants; work against South African strain on: Govt

South Africa, Brazil mutated Covid strains have reached India

Those on blood thinners can receive vaccine, says ICMR

No irregularity in approval to Covaxin: ICMR

Emergency use of vaccine is based on safety, immunogenicity data, says ICMR chief

ICMR chief Balram Bhargava admitted to AIIMS after testing positive for COVID-19

ICMR chief Balram Bhargava undergoing treatment for Covid-19 at AIIMS Trauma Centre

‘Adverse event’ won’t affect vaccine rollout plan: Government

‘No vaccine for respiratory diseases has 100% efficacy’

Govt asks states to upload rapid antigen testing data on ICMR portal

Two indigenous Indian vaccines cleared to start human trials, each has 1,000 volunteers

No vaccine before 2021, science minister says in release, deletes it

India is not in community transmission: ICMR

'No harm, potential benefits': ICMR continues recommendation on use of hydroxychloroquine for preventive treatment

Centre asks states to set up exclusive facilities for treating covid-19 patients

72 functional labs for coronavirus testing, private players to be engaged soon: ICMR